Today, David Fingold commented about whether SKFOF-OTC, LONN-SW, STRS-TASE, 7741-JP, MSFT-Q, LHX-N, PRU-N, PAYX-Q, CVS-N, MS-N, SYK-N, PGR-N, ESLT-Q, RDS.A-N, GOOG-Q, NSRGY-OTC, RTX-N are stocks to buy or sell.
He's moved to the sidelines on Google, because ads are their primary revenues. In every recession, ad revenues fall hard. He owns Amazon, which already earns ad revenues. It's early to get exposure to advertising, because ad budgets may get cut in the near term. But if this is a short recession that'll end in the summer, then the market may be looking past the recession already.
Likes it. He hasn't bought it, because he isn't sure which stock to own in this sector. Abbott and Boston Scientific are better choices, he thinks, with more upside potential given product innovation.
Healthcare is one of the best three sectors over the last 50 years. Eli Lily is a better choice. He's not in drugstores, because they are cyclical, such as 2008-9 when they got hit in a slow economy. Drugstores make their money buying impulse items in addition to their drugs, and people don't buy in tough times. He suggest Costco which fulfills prescriptions, but sells groceries. And Amazon is getting into this space.
A great company, a top cloud player. But a company needs advanced IT department to use Amazon's cloud service, whereas MSFT can support small/medium-sized software developers can sell them over MSFT's cloud. MSFT has been tested through fire and have passed the test during this pandemic, proving that their cloud services continue to work during massive use as people continue to work from home. MSFT has the right stuff.